USD636865S1 - Pharmaceutical tablet - Google Patents

Pharmaceutical tablet Download PDF

Info

Publication number
USD636865S1
USD636865S1 US29/370,714 US37071410F USD636865S US D636865 S1 USD636865 S1 US D636865S1 US 37071410 F US37071410 F US 37071410F US D636865 S USD636865 S US D636865S
Authority
US
United States
Prior art keywords
pharmaceutical tablet
pharmaceutical
tablet
view
elevational view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/370,714
Inventor
Kalyan Vepuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KVK Tech Inc
Original Assignee
KVK Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KVK Tech Inc filed Critical KVK Tech Inc
Priority to US29/370,714 priority Critical patent/USD636865S1/en
Application granted granted Critical
Publication of USD636865S1 publication Critical patent/USD636865S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a perspective view from above and one side of the pharmaceutical tablet showing my new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a front elevational view of the pharmaceutical tablet of FIG. 1 with the top thereof upwardly facing;
FIG. 5 is a rear elevational view of the pharmaceutical tablet of FIG. 1 with the top thereof downwardly facing;
FIG. 6 is a side elevational view of the pharmaceutical tablet with the top facing left; and,
FIG. 7 is a further side elevational view of the pharmaceutical tablet opposite from that of FIG. 6 and with the top facing right.

Claims (1)

  1. The ornamental design for a pharmaceutical tablet, as shown and described.
US29/370,714 2010-08-25 2010-08-25 Pharmaceutical tablet Active USD636865S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/370,714 USD636865S1 (en) 2010-08-25 2010-08-25 Pharmaceutical tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/370,714 USD636865S1 (en) 2010-08-25 2010-08-25 Pharmaceutical tablet

Publications (1)

Publication Number Publication Date
USD636865S1 true USD636865S1 (en) 2011-04-26

Family

ID=43880869

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/370,714 Active USD636865S1 (en) 2010-08-25 2010-08-25 Pharmaceutical tablet

Country Status (1)

Country Link
US (1) USD636865S1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) * 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD941985S1 (en) * 2020-04-07 2022-01-25 Nutramax Laboratories, Inc. Dietary supplement

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD741990S1 (en) * 2013-07-30 2015-10-27 Reckitt Benckiser Llc Tablet
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD906513S1 (en) * 2019-03-19 2020-12-29 Novo Nordisk A/S Pill
USD947358S1 (en) 2019-03-19 2022-03-29 Novo Nordisk A/S Pill
USD941985S1 (en) * 2020-04-07 2022-01-25 Nutramax Laboratories, Inc. Dietary supplement

Similar Documents

Publication Publication Date Title
USD678271S1 (en) Tablet PC
USD673950S1 (en) Tablet computer
USD641018S1 (en) Tablet computer
USD640255S1 (en) Tablet computer
USD675203S1 (en) Tablet PC
USD687820S1 (en) Tablet computer
USD678270S1 (en) Tablet computer
USD687825S1 (en) Tablet computer
USD664954S1 (en) Tablet computer
USD664540S1 (en) Tablet computer
USD664955S1 (en) Tablet computer
USD659692S1 (en) Tablet computer
USD687826S1 (en) Tablet computer
USD687824S1 (en) Tablet computer
USD687827S1 (en) Tablet computer
USD702228S1 (en) Tablet computer
USD656497S1 (en) Tablet PC
USD641237S1 (en) Container
USD692423S1 (en) Tablet computer
USD662932S1 (en) Tablet PC
USD674649S1 (en) Straw
USD636865S1 (en) Pharmaceutical tablet
USD631358S1 (en) Container
USD700180S1 (en) Tablet computer
USD701201S1 (en) Tablet computer